Nathan Thielman
Director, Global Health Pathway for Residents and Fellows
Professor of Medicine
Research Professor of Global Health
Professor of Pathology
Appointment:
Countries:
Nathan Thielman
Director, Global Health Pathway for Residents and Fellows
Professor of Medicine
Research Professor of Global Health
Professor of Pathology
Nathan Thielman, MD, MPH, an infectious diseases physician, is Professor of Medicine, Pathology and Global Health at Duke University. Broadly, Dr. Thielman's research focuses on clinical and social issues that affect persons living with or at risk for HIV infection in low-resource settings. He is Director of the Global Health Pathway for Residents and Fellows and Co-Director of Duke's NIH-funded Interdisciplinary Research Training Program in AIDS. He is a past member of the Advisory Council of the National Institute of Allergy and Infectious Diseases and served on the CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment.
Projects
-
Global Health Pathway for Residents and Fellows
Myanmar, Nepal, Nicaragua, Peru, Rwanda, South Africa, Sri Lanka, Tanzania, Thailand, United States, Vietnam, Brazil, India, Kenya
Publications
-
Abernethy ER, Sakita FM, Sumner SF, Bashaka P, Kilungu A, Mulesi EM, et al. The prevalence of HIV among patients with cardiovascular disease in a Tanzanian emergency department: results from a prospective observational study. AIDS Care. 2025 Dec 15;1–11.Hertz JT, Nworie JE, Shayo F, Galson SW, Coaxum LA, Daniel I, et al. Acute myocardial infarction diagnosis and treatment following implementation of a multicomponent intervention in Tanzania: the MIMIC pilot trial. BMJ Open. 2025 Nov 11;15(11):e107857.Patel SM, Farirai J, Patel MZ, Boiditswe S, Tawe L, Lekalake S, et al. Alterations of the Upper Respiratory Microbiome Among Children Living With HIV Infection in Botswana. J Infect Dis. 2025 Oct 15;232(4):815–25.van Zwetselaar M, Ostermann J, Beti M, Baumgartner JN, Mfinanga S, Ngadaya E, et al. Design of an Automated Mobile Phone-Based Reminder and Incentive System: Application in a Quasi-Randomized Controlled Trial to Improve the Timeliness of Childhood Vaccinations in Tanzania. JMIR Form Res. 2025 Sep 10;9:e65150.
See more publications at Scholars@Duke


